e-learning
resources
London 2016
Tuesday, 06.09.2016
Asthma points to ponder
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Asthma-associated factors - Potential predictive markers for patients stratification, personalized treatments and prevention
Liudmyla Petrenko (Kyiv, Ukraine), Rostyslav Bubnov, Liudmyla Petrenko
Source:
International Congress 2016 – Asthma points to ponder
Session:
Asthma points to ponder
Session type:
Poster Discussion
Number:
3366
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Liudmyla Petrenko (Kyiv, Ukraine), Rostyslav Bubnov, Liudmyla Petrenko. Asthma-associated factors - Potential predictive markers for patients stratification, personalized treatments and prevention. Eur Respir J 2016; 48: Suppl. 60, 3366
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Identifying patients at risk for future exacerbations of asthma: Development of a prediction model
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Novel proteomic biomarkers in the evaluation of childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
A follow-up of patients with a new diagnosis of asthma - characteristics, prognosis and risk factors
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Positive bronchodilator response is a poor predictor of future risk in well controlled asthma patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
What is important to people with asthma: Maximising research impact?
Source: International Congress 2015 – Any news from the asthma field?
Year: 2015
Allergen specific immunotherapy: Effect on immunological markers and clinical outcomes in asthmatic children
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
The potential role of bronchial challenge testing to identify overtreatment of community managed asthma
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
A new clinically relevant method of calculating adherence
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases
Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Year: 2015
Bronchial asthma (BA) pharmacogenetic profile and therapeutic resistance in slavic population
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Metrics of salbutamol use as predictors of future adverse outcomes in asthma
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013
Study the role of eNO-synthasegene polymorphism in patients with asthma and obesity
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Assessing asthma risk in primary care: Can the AAA test predict future asthma attacks?
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept